Capped Oligonucleotide Primers for High-Yield 5'-Capped RNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing 5'-capped RNA are laborious, inefficient, costly, and result in low yields with significant production of heterogeneous products and require additional enzymatic steps for Cap 1 and Cap 2 structures, while also facing issues with bi-directional initiation and immunogenicity.
Innovation Solution
The use of initiating capped oligonucleotide primers with specific structures to initiate transcription, allowing for the synthesis of 5'-capped RNA molecules with Cap 0, Cap 1, or Cap 2 structures, which are complementary to the promoter sequence, reducing the need for additional enzymatic steps and improving yield and reducing immunogenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional enzymatic capping methods are used to synthesize 5'-capped RNA, then Cap structures can be introduced, but the process becomes laborious and inefficient with low yields
Solution Approach 1:
The patent incorporates the Cap structure directly into the initiating oligonucleotide primer before transcription begins. This preliminary incorporation eliminates the need for subsequent enzymatic capping steps, directly resolving the contradiction by achieving both high capping efficiency (all transcripts start with the capped primer) and high productivity (single-step synthesis without additional processing steps).
Solution Approach 2:
The patent extracts the capping step from the transcription process by using pre-capped primers. Instead of performing enzymatic capping as a separate subsequent step, the Cap structure is already present on the primer that initiates transcription, thereby eliminating the laborious enzymatic step while maintaining high capping efficiency.
2Reliability
If enzymatic steps are added to create Cap 1 and Cap 2 structures, then translation efficacy and nuclease stability improve, but the process complexity and cost increase
Solution Approach 1:
The patent applies local quality by incorporating 2'-O-methyl modifications specifically at the Cap 1 and Cap 2 positions of the initiating primer. This localized modification approach achieves the desired translation efficacy and nuclease stability improvements without requiring global enzymatic processing, thereby reducing process complexity while maintaining the beneficial local properties at critical positions.
Solution Approach 2:
The patent performs preliminary action by pre-installing the 2'-O-methyl modifications at Cap 1 and Cap 2 positions during primer synthesis before the transcription reaction. This eliminates the need for subsequent enzymatic methylation steps, reducing process complexity while ensuring the translated efficacy and stability benefits are already present in the final RNA product.
3Productivity
If standard initiation methods are used, then transcription can proceed, but bi-directional initiation occurs and heterogeneous products are produced
Solution Approach 1:
The patent applies asymmetry by designing the initiating primer with a specific 5'-cap structure that is asymmetric and directional. This asymmetric cap structure ensures that transcription initiation occurs in only one direction (5' to 3'), preventing bi-directional initiation and the formation of heterogeneous products, thereby improving manufacturing precision while maintaining transcription efficiency.
Solution Approach 2:
The patent changes the parameter of the initiating nucleotide by using a capped oligonucleotide primer instead of standard uncapped primers or NTPs. This parameter change (incorporating the Cap structure with specific chemical properties) alters the initiation mechanism to favor unidirectional transcription, eliminating bi-directional initiation and producing homogeneous RNA products while maintaining high transcription efficiency.
4Ease of manufacture
If 5'-triphosphate mRNA is produced without Cap structure, then synthesis is simpler, but immunogenicity increases and translation activity is lost
Solution Approach 1:
The patent performs preliminary action by incorporating the protective Cap structure into the initiating primer before transcription begins. This preliminary incorporation ensures that the final RNA product has the Cap structure already in place, which prevents immunogenicity and maintains translation activity without requiring additional post-transcriptional processing steps, thus maintaining synthesis simplicity while eliminating harmful effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the synthesis efficiency, reduces costs, minimizes heterogeneous products, and ensures high yields of 5'-capped RNA with improved translation activity and reduced immunogenicity.
Implementation Method 1
introducing an initiating capped oligonucleotide primer into a mixture comprising a polynucleotide template and an RNA polymerase under conditions conducive to transcription by the RNA polymerase of the polynucleotide template
Implementation Method 2
RNA polymerase under conditions conducive to transcription by the RNA polymerase of the polynucleotide template
Data Source
Figure 1~2
Figure 3~5
Figure 6~7
AI summary
Provided herein are methods and compositions for synthesizing 5'Capped RNAs wherein the initiating capped oligonucleotide primers have the general form m7Gppp[N2'Ome]n[N]m wherein m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, "n" can be any integer from 0 to 4 and "m" can be an integer from 1 to 9.